Interestingly, IRF1 and a variant of heterogeneous nuclear ribonucleoprotein L (Lv1) coordinately regulate CEACAM1 transcription, alternative splicing, and translation, and may significantly contribute to CEACAM1 silencing in cancer [169]. This evidence concerns the gene IRF1 and cancer.